Understanding Goserelin Treatment for Premenopausal Breast Cancer

Goserelin (brand name Zoladex) is a hormone therapy used to treat estrogen receptor (ER) positive breast cancer in premenopausal women. Since estrogen can fuel breast cancer growth, blocking estrogen production is a common treatment approach. Goserelin works by reducing estrogen levels through a process called ovarian suppression.

How does Goserelin suppress estrogen levels?

Goserelin is what’s known as a luteinizing hormone-releasing hormone (LHRH) agonist. LHRH is produced in the brain to signal the ovaries to make estrogen and release eggs during the monthly menstrual cycle.

Goserelin mimics LHRH, overstimulating hormone receptors in the pituitary gland in the brain. This causes the pituitary gland to temporarily stop telling the ovaries to produce estrogen and release eggs.

Within 1-2 weeks of the first Goserelin injection, estrogen levels drop sharply as ovarian function is suppressed into an induced menopause-like state. Periods usually stop within the first month as well.

When is Goserelin used for breast cancer treatment?

For premenopausal women diagnosed with ER-positive early stage or locally advanced breast cancer, Goserelin is typically given along with chemotherapy and continued for up to 5 years in total. This helps stop estrogen from further fueling cancer growth after chemotherapy ends.

Goserelin can be used alone or with other hormone therapies like tamoxifen or aromatase inhibitors as well, depending on the cancer specifics. For those with metastatic breast cancer, it may be continued long-term if the cancer responds well.

Suppressing ovarian function temporarily puts the body into a reversible menopausal state. This avoids the tumor protection from the cell cycling effects of natural menstrual periods during chemotherapy.

How is the Goserelin implant administered?

  • Goserelin comes as a subcutaneous implant injected under the skin, typically of the abdomen
  • The injection takes just a minute and feels similar to a pinprick
  • A small rice-sized capsule releases Goserelin slowly over 1 month before needing replacement
  • Appointments are required every 4 weeks for new implant injections
  • Treatment lasts for up to 5 years depending on clinical situation

During the office visits, your oncology team will monitor for side effects, review bloodwork results, perform physical exams, and order imaging tests periodically to check treatment effectiveness.

What are the expected side effects?

Inducing temporary menopause comes with known side effects similar to natural menopause’s symptoms. Most side effects from Goserelin are temporary and improve over time as the body adjusts to lower hormone levels.

  • Hot flashes – Sudden feelings of intense body heat, flushing red skin and sweating are very common early on
  • Vaginal dryness – Thinning and dryness of vaginal tissues leading to painful intercourse, irritation, and discharge
  • Mood changes – Increased irritability, anxiety, sadness, trouble sleeping or mental fogginess
  • Painful joints/bones – Stiffness, achiness or joint pain resulting from lowering estrogen levels
  • Fatigue – Lack of energy, tiring more easily or feeling slowed down are often reported
  • Headaches – Tension, migraine or other headache types may newly develop or worsen
  • Weight gain – Despite no change in diet, small weight gains of 5-10 lbs are common
  • Lower libido – Decreased sex drive resulting from hormone suppression

Rare but serious risks include bone density loss or osteoporosis over time and slightly elevated cholesterol levels. Regular monitoring helps detect any concerning trends early.

Note: The above reflects common side effects seen in clinical studies but each woman responds uniquely based on health status, genetics and other factors. Stay actively engaged with your care team in reporting any side effects or concerns promptly.

Coping with menopausal side effects

The good news is most side effects become less frequent and intense after the first few months once the body adjusts to the new hormonal state. However, some women continue experiencing effects like hot flashes periodically throughout treatment.

  • Vaginal moisturizers, lubricants and estradiol creams alleviate uncomfortable vaginal dryness
  • Practicing relaxation techniques, getting enough sleep and avoiding triggers can help hot flashes
  • Light exercise like walking helps joint stiffness, fatigue and mood issues for many
  • Avoiding smoking, alcohol and spicy foods reduces hot flash frequency and severity
  • Over-the-counter pain relievers treat headaches or general achiness
  • Counseling provides support coping with anxiety, sadness and self-image changes

Speaking with your care team for personalized recommendations provides the greatest relief. Most women find side effects manageable knowing the treatment is effective at slowing breast cancer growth by shutting down estrogen production temporarily.

Special considerations about fertility and contraception

Since Goserelin pauses ovulation and menstrual periods, fertility is impacted but not eliminated completely. Rare ovarian activity resulting in intermittent egg release can still occur. Although periods stop, pregnancy is still possible so using non-hormonal contraception like condoms or a copper IUD is essential during treatment.

If considering future pregnancy, options like embryo or egg freezing should be discussed before starting Goserelin. Fertility preservation decisions depend heavily on cancer type, staging, time available before treatment and personal considerations, so individualized counseling is key.

While some women’s periods and fertility restart after finishing treatment, this is variable and pregnancy outcomes afterwards remain uncertain. Embryo/egg freezing offers the best chance of future fertility.

What’s the typical treatment timeline?

Most patients receive Goserelin injections for 5 years total. The first 6 months are focused on completing chemotherapy and/or radiation if applicable while the Goserelin prevents periods and lowered estrogen levels protect cancer cells.

  • After completing chemo/radiation:
    • Months 6-12 – Side effects slowly improve while continuing Goserelin
    • Years 1-5 – Ongoing Goserelin to stop estrogen fueling any remaining cancer cells

If cancer recurs or spreads elsewhere in the body despite initial treatments, Goserelin may be continued indefinitely as it can keep helping control cancers growth.

Through regular exams and periodic imaging, the care team carefully monitors treatment effectiveness and cancer status. If significant disease progression occurs at any point, the oncologist will discuss adjusting therapy approaches promptly.

In conclusion

Goserelin is an established treatment for premenopausal breast cancer, providing ovarian suppression to lower estrogen fueling cancer growth. Despite menopausal side effects often being challenging initially, most stabilize within 6-12 months allowing women to complete the 5-year course protecting against recurrence.

Combining Goserelin with chemotherapy or other anti-estrogen drugs prolongs lives for many patients compared to chemotherapy alone. Through close monitoring and reporting side effects promptly, most premenopausal women can safely tolerate Goserelin long enough to gain its cancer fighting benefits.

More from this topic

Aromatase Inhibitors